Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
97.83
-0.40 (-0.41%)
At close: Sep 19, 2025, 4:00 PM EDT
97.70
-0.13 (-0.13%)
After-hours: Sep 19, 2025, 7:57 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts that cover Boston Scientific stock have a consensus rating of "Strong Buy" and an average price target of $118.91, which forecasts a 21.55% increase in the stock price over the next year. The lowest target is $100 and the highest is $135.
Price Target: $118.91 (+21.55%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 10 | 10 | 10 | 10 |
| Buy | 10 | 10 | 11 | 11 | 11 | 12 |
| Hold | 1 | 1 | 1 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 22 | 23 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $121 | Strong Buy | Reiterates | $121 | +23.68% | Sep 19, 2025 |
| Needham | Needham | Strong Buy Reiterates $121 | Strong Buy | Reiterates | $121 | +23.68% | Sep 11, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $118 → $125 | Hold → Buy | Upgrades | $118 → $125 | +27.77% | Sep 8, 2025 |
| UBS | UBS | Strong Buy Maintains $130 → $135 | Strong Buy | Maintains | $130 → $135 | +37.99% | Jul 24, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $121 → $124 | Strong Buy | Maintains | $121 → $124 | +26.75% | Jul 24, 2025 |
Financial Forecast
Revenue This Year
20.05B
from 16.75B
Increased by 19.75%
Revenue Next Year
22.27B
from 20.05B
Increased by 11.03%
EPS This Year
3.01
from 1.25
Increased by 140.98%
EPS Next Year
3.43
from 3.01
Increased by 13.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0B | 23.6B | |||
| Avg | 20.1B | 22.3B | |||
| Low | 19.2B | 21.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.3% | 17.6% | |||
| Avg | 19.7% | 11.0% | |||
| Low | 14.8% | 6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.19 | 3.80 | |||
| Avg | 3.01 | 3.43 | |||
| Low | 2.90 | 3.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 155.4% | 26.2% | |||
| Avg | 141.0% | 13.9% | |||
| Low | 132.1% | 5.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.